MAPK8 and Parkinson disease: In addition, BE treatment significantly inhibited p38, ERK 1/2, and JNK activation in the brains of PD rats, suggesting that BE can exert an anti-inflammatory effect in PD rats through the MAPK pathway (Zhang et al., 2017).